Law360, New York (November 15, 2007, 12:00 AM ET) -- Wyeth has been slammed by a proposed shareholder class action alleging that the pharmaceuticals giant made false and misleading statements about its depression and menopause drug Pristiq.
The law firm Coughlin, Stoia, Geller, Rudman & Robbins LLP announced on Wednesday that it had lodged the lawsuit in the U.S. District Court in Manhattan, accusing Wyeth of hiding negative data about Pristiq's effects when it filed a New Drug Application in June 2006.
A spokesman for Wyeth declined to comment.
The lawsuit was filed on behalf of...
Wyeth Hit With Securities Suit Over Menopause Drug
To view the full article, take a free trial now.
